| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH |
|
|
|
||||||||
|
||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dr. Jemal is Strategic Director, Cancer Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Hao is Senior Epidemiologist, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Xu is Epidemiologist, Mortality Statistics Branch, Division of Vital Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
ABSTRACT
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,437,180 new cancer cases and 565,650 deaths from cancer are projected to occur in the United States in 2008. Notable trends in cancer incidence and mortality include stabilization of incidence rates for all cancer sites combined in men from 1995 through 2004 and in women from 1999 through 2004 and a continued decrease in the cancer death rate since 1990 in men and since 1991 in women. Overall cancer death rates in 2004 compared with 1990 in men and 1991 in women decreased by 18.4% and 10.5%, respectively, resulting in the avoidance of over a half million deaths from cancer during this time interval. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. Although much progress has been made in reducing mortality rates, stabilizing incidence rates, and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  P. Pallante, R. Visone, C. M. Croce, and A. Fusco Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas Endocr. Relat. Cancer, March 1, 2010; 17(1): F91 - F104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R C M Simmen, J M P Pabona, M C Velarde, C Simmons, O Rahal, and F A Simmen The emerging role of Kruppel-like factors in endocrine-responsive cancers of female reproductive tissues J. Endocrinol., March 1, 2010; 204(3): 223 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Simon, F. Zhang, S. B. Soumerai, A. Ensroth, L. Bernstein, R. H. Fletcher, and D. Ross-Degnan Failure of Automated Telephone Outreach With Speech Recognition to Improve Colorectal Cancer Screening: A Randomized Controlled Trial Arch Intern Med, February 8, 2010; 170(3): 264 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Tunio, A. Hashmi, and M. Rafi Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials Ann. Onc., February 5, 2010; (2010) mdq028v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lonn, E. S. Gilbert, E. Ron, S. A. Smith, M. Stovall, and R. E. Curtis Comparison of Second Cancer Risks from Brachytherapy and External Beam Therapy After Uterine Corpus Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2010; 19(2): 464 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Liu, H. G. Vikis, Y. Lu, Y. Wang, A. G. Schwartz, S. M. Pinney, P. Yang, M. de Andrade, A. Gazdar, C. Gaba, et al. Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2010; 19(2): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Barua, P. Bitterman, J. M. Bahr, M. J. Bradaric, D. B. Hales, J. L. Luborsky, and J. S. Abramowicz Detection of Tumor-Associated Neoangiogenesis by Doppler Ultrasonography During Early-Stage Ovarian Cancer in Laying Hens: A Preclinical Model of Human Spontaneous Ovarian Cancer J. Ultrasound Med., February 1, 2010; 29(2): 173 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Adjei, S. J. Mandrekar, G. K. Dy, J. R. Molina, A. A. Adjei, D. R. Gandara, K. L. A. Ziegler, P. J. Stella, K. M. Rowland Jr, S. E. Schild, et al. Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non-Small-Cell Lung Cancer: NCCTG and SWOG Study N0426 J. Clin. Oncol., February 1, 2010; 28(4): 614 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Ferreira, R. A. de Oliveira, L. B. Jorge, W. C. Nahas, L. B. Saldanha, L. E. Ianhez, and M. Srougi Urothelial carcinoma transmission via kidney transplantation Nephrol. Dial. Transplant., February 1, 2010; 25(2): 641 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hall, M. A. Barhoover, D. Kazmin, D. P. McDonnell, W. F. Greenlee, and R. S. Thomas Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation Mol. Endocrinol., February 1, 2010; 24(2): 359 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Nagaraja, C. J. Creighton, Z. Yu, H. Zhu, P. H. Gunaratne, J. G. Reid, E. Olokpa, H. Itamochi, N. T. Ueno, S. M. Hawkins, et al. A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer Mol. Endocrinol., February 1, 2010; 24(2): 447 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Lim, K.-C. Chun, S.-J. Shin, I. H. Lee, K. T. Lim, C. H. Cho, S.-Y. Park, and J.-H. Nam Clinical Presentation of Endometrioid Epithelial Ovarian Cancer with Concurrent Endometriosis: A Multicenter Retrospective Study Cancer Epidemiol. Biomarkers Prev., February 1, 2010; 19(2): 398 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kassie, S. Kalscheuer, I. Matise, L. Ma, T. Melkamu, P. Upadhyaya, and S. S. Hecht Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice Carcinogenesis, February 1, 2010; 31(2): 239 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rineer, D. Schreiber, E. Katsoulakis, T. Nabhani, P. Han, C. Lange, K. Choi, and M. Rotman Survival Following Sublobar Resection for Early-Stage Non-Small Cell Lung Cancer With or Without Adjuvant External Beam Radiation Therapy: A Population-Based Study Chest, February 1, 2010; 137(2): 362 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Wirth, A. M. Allen, M. R. Posner, R. I. Haddad, Y. Li, J. R. Clark, P. M. Busse, A. W. Chan, L. A. Goguen, C. M. Norris, et al. Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck Ann. Onc., February 1, 2010; 21(2): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lei, E. M. Sturgis, Z. Liu, M. E. Zafereo, Q. Wei, and G. Li Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck Carcinogenesis, February 1, 2010; 31(2): 222 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Galanis, L. C. Hartmann, W. A. Cliby, H. J. Long, P. P. Peethambaram, B. A. Barrette, J. S. Kaur, P. J. Haluska Jr., I. Aderca, P. J. Zollman, et al. Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer Cancer Res., February 1, 2010; 70(3): 875 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hofland, W. M. van Weerden, N. F.J. Dits, J. Steenbergen, G. J.L.H. van Leenders, G. Jenster, F. H. Schroder, and F. H. de Jong Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer Cancer Res., February 1, 2010; 70(3): 1256 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Jia, Y. Gao, L. Wang, Q. Li, J. Zhang, X. Le, D. Wei, J. C. Yao, D. Z. Chang, S. Huang, et al. Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity Cancer Res., February 1, 2010; 70(3): 1111 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Logan-Collins, R. M. Thomas, P. Yu, D. Jaquish, E. Mose, R. French, W. Stuart, R. McClaine, B. Aronow, R. M. Hoffman, et al. Silencing of RON Receptor Signaling Promotes Apoptosis and Gemcitabine Sensitivity in Pancreatic Cancers Cancer Res., February 1, 2010; 70(3): 1130 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ma, Y. Park, S. T. Mayne, R. Wang, R. Sinha, A. R. Hollenbeck, A. Schatzkin, and A. J. Cross Diet, Lifestyle, and Acute Myeloid Leukemia in the NIH-AARP Cohort Am. J. Epidemiol., February 1, 2010; 171(3): 312 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Li, J. Lu, Z. Liu, L.-E. Wang, H. Zhao, A. K. El-Naggar, E. M. Sturgis, and Q. Wei The Six-Nucleotide Deletion/Insertion Variant in the CASP8 Promoter Region Is Inversely Associated with Risk of Squamous Cell Carcinoma of the Head and Neck Cancer Prevention Research, February 1, 2010; 3(2): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kim, W. K. Hong, J. J. Lee, L. Mao, R. C. Morice, D. D. Liu, C. A. Jimenez, G. A. Eapen, R. Lotan, X. Tang, et al. Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers Cancer Prevention Research, February 1, 2010; 3(2): 148 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Keefe, M. A. Cohen, and M. S. Brose Targeting Vascular Endothelial Growth Factor Receptor in Thyroid Cancer: The Intracellular and Extracellular Implications Clin. Cancer Res., February 1, 2010; 16(3): 778 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Boeck, M. Haas, R. P. Laubender, F. Kullmann, C. Klose, C. J. Bruns, R. Wilkowski, P. Stieber, S. Holdenrieder, H. Buchner, et al. Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer Clin. Cancer Res., February 1, 2010; 16(3): 986 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V Krishnan and D. Feldman Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment Endocr. Relat. Cancer, January 29, 2010; 17(1): R19 - R38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Hung, M. A. Maricevich, L. G. Richard, W. Y. Chen, M. P. Richardson, A. Kunin, R. T. Bronson, U. Mahmood, and R. Kucherlapati Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment PNAS, January 26, 2010; 107(4): 1565 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-E Wang, Z. Hu, E. M. Sturgis, M. R. Spitz, S. S. Strom, C. I. Amos, Z. Guo, Y. Qiao, A. M. Gillenwater, J. N. Myers, et al. Reduced DNA Repair Capacity for Removing Tobacco Carcinogen-Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics Clin. Cancer Res., January 15, 2010; 16(2): 764 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Finn Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now? Clin. Cancer Res., January 15, 2010; 16(2): 390 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Beleford, Z. Liu, R. Rattan, L. Quagliuolo, M. Boccellino, A. Baldi, J. Maguire, J. Staub, J. Molina, and V. Shridhar Methylation Induced Gene Silencing of HtrA3 in Smoking-Related Lung Cancer Clin. Cancer Res., January 15, 2010; 16(2): 398 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rasool, W. LaRochelle, H. Zhong, G. Ara, J. Cohen, and E. C. Kohn Secretory Leukocyte Protease Inhibitor Antagonizes Paclitaxel in Ovarian Cancer Cells Clin. Cancer Res., January 15, 2010; 16(2): 600 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Du, S. M. Martin, M. Levine, B. A. Wagner, G. R. Buettner, S.-h. Wang, A. F. Taghiyev, C. Du, C. M. Knudson, and J. J. Cullen Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer Clin. Cancer Res., January 15, 2010; 16(2): 509 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Boonstra, R. van Marion, D. G. Beer, L. Lin, P. Chaves, C. Ribeiro, A. D. Pereira, L. Roque, S. J. Darnton, N. K. Altorki, et al. Verification and Unmasking of Widely Used Human Esophageal Adenocarcinoma Cell Lines J Natl Cancer Inst, January 14, 2010; (2010) djp499v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-R. He, H.-Y. Zhao, B.-K. Li, L.-J. Zhang, M.-Z. Liu, H.-F. Kung, X.-Y. Guan, X.-W. Bian, Y.-X. Zeng, and D. Xie Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients Ann. Onc., January 11, 2010; (2010) mdp592v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kutikov, B. L. Egleston, Y.-N. Wong, and R. G. Uzzo Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram J. Clin. Oncol., January 10, 2010; 28(2): 311 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Anderson, I. Jatoi, J. Tse, and P. S. Rosenberg Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer J. Clin. Oncol., January 10, 2010; 28(2): 232 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Whitman, M. Pomerantz, Y. Chen, M. M. Chamberlin, B. Furusato, C. Gao, A. Ali, L. Ravindranath, A. Dobi, I. A. Sestrehenn, et al. Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jayachandran, W. J. Aronson, M. K. Terris, J. C. Presti Jr., C. L. Amling, C. J. Kane, and S. J. Freedland Diabetes and Outcomes After Radical Prostatectomy: Are Results Affected by Obesity and Race? Results from the Shared Equal-Access Regional Cancer Hospital Database Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Langeberg, E. M. Kwon, J. S. Koopmeiners, E. A. Ostrander, and J. L. Stanford Population-Based Study of the Association of Variants in Mismatch Repair Genes with Prostate Cancer Risk and Outcomes Cancer Epidemiol. Biomarkers Prev., January 1, 2010; 19(1): 258 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Goss, A. Arnold, F. A. Shepherd, M. Dediu, T.-E. Ciuleanu, D. Fenton, M. Zukin, D. Walde, F. Laberge, M. D. Vincent, et al. Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non-Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study J. Clin. Oncol., January 1, 2010; 28(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hsu, T. M Bray, W. G Helferich, D. R Doerge, and E. Ho Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells Exp Biol Med, January 1, 2010; 235(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhao, J. Zhu, X. Ji, J. Cai, F. Wan, Q. Li, B. Zhong, S. Tucker, and D. Wang A Phase II Study of Irinotecan and Capecitabine for Patients with Unresectable Liver-only Metastases from Colorectal Cancer Jpn. J. Clin. Oncol., January 1, 2010; 40(1): 10 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Alexander Jr, D. L. Fraker, D. L. Bartlett, S. K. Libutti, S. M. Steinberg, P. Soriano, and T. Beresnev Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters J. Clin. Oncol., January 1, 2010; 28(1): 114 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. DuSell, E. R. Nelson, B. M. Wittmann, J. A. Fretz, D. Kazmin, R. S. Thomas, J. W. Pike, and D. P. McDonnell Regulation of Aryl Hydrocarbon Receptor Function by Selective Estrogen Receptor Modulators Mol. Endocrinol., January 1, 2010; 24(1): 33 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Y.C. Heng, C. Kollmannsberger, and K. N. Chi Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions Therapeutic Advances in Medical Oncology, January 1, 2010; 2(1): 39 - 49. [Abstract] [PDF]
|
|
|
|
|
|
A. K. Agarwala and N. H. Hanna Review: Advanced non-small cell lung cancer: the role of maintenance therapy Therapeutic Advances in Medical Oncology, January 1, 2010; 2(1): 17 - 23. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Kagawa-Singer, A. Valdez Dadia, M. C. Yu, and A. Surbone Cancer, Culture, and Health Disparities: Time to Chart a New Course? CA Cancer J Clin, January 1, 2010; 60(1): 12 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Robinson, R. Turrisi, K. Mallett, J. Stapleton, and M. Pion Comparing the Efficacy of an In-Person Intervention With a Skin Self-examination Workbook Arch Dermatol, January 1, 2010; 146(1): 91 - 94. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yang, M. C. Cheung, M. M. Byrne, X. Jin, A. J. Montero, C. Jones, and L. G. Koniaris Survival Effects of Adjuvant Chemoradiotherapy After Resection for Pancreatic Carcinoma Arch Surg, January 1, 2010; 145(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Bailey, K. Kim, A. K. Verma, K. Sielaff, P. O. Larson, S. Snow, T. Lenaghan, J. L. Viner, J. Douglas, N. E. Dreckschmidt, et al. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of {alpha}-Difluoromethylornithine in Subjects with Previous History of Skin Cancer Cancer Prevention Research, January 1, 2010; 3(1): 35 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Dimou, B. Van Calster, S. Van Huffel, D. Timmerman, and M. Zervakis Evaluation of Imputation Methods in Ovarian Tumor Diagnostic Models Using Generalized Linear Models and Support Vector Machines Med Decis Making, January 1, 2010; 30(1): 123 - 131. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Weiler-Sagie, O. Bushelev, R. Epelbaum, E. J. Dann, N. Haim, I. Avivi, A. Ben-Barak, Y. Ben-Arie, R. Bar-Shalom, and O. Israel 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients J. Nucl. Med., January 1, 2010; 51(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zheng, X.-X. Cui, Z. Gao, Y. Zhao, Y. Lin, W. J. Shih, M.-T. Huang, Y. Liu, A. Rabson, B. Reddy, et al. Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence Cancer Prevention Research, January 1, 2010; 3(1): 114 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, C.-L. Sun, B. Mailey, C. Prendergast, A. Artinyan, S. Bhatia, A. Pigazzi, and J. D. I. Ellenhorn Race and ethnicity correlate with survival in patients with gastric adenocarcinoma Ann. Onc., January 1, 2010; 21(1): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Chung, W. C. S. Magalhaes, J. Gonzalez-Bosquet, and S. J. Chanock Genome-wide association studies in cancer--current and future directions Carcinogenesis, January 1, 2010; 31(1): 111 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Cronin, R. Swords, M. T. Truong, C. Viswanathan, E. Rohren, F. J. Giles, M. O'Dwyer, and J. F. Bruzzi Clinical Utility of PET/CT in Lymphoma Am. J. Roentgenol., January 1, 2010; 194(1): W91 - W103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kohli and D. J. Tindall New Developments in the Medical Management of Prostate Cancer Mayo Clin. Proc., January 1, 2010; 85(1): 77 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Eide, R. Krajenta, D. Johnson, J. J. Long, G. Jacobsen, M. M. Asgari, H. W. Lim, and C. C. Johnson Identification of Patients With Nonmelanoma Skin Cancer Using Health Maintenance Organization Claims Data Am. J. Epidemiol., January 1, 2010; 171(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. El-Sahwi, S. Bellone, E. Cocco, F. Casagrande, M. Bellone, M. Abu-Khalaf, N. Buza, F. A. Tavassoli, P. Hui, D. Ruttinger, et al. Overexpression of EpCAM in Uterine Serous Papillary Carcinoma: Implications for EpCAM-Specific Immunotherapy With Human Monoclonal Antibody Adecatumumab (MT201) Mol. Cancer Ther., January 1, 2010; 9(1): 57 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Behrens, L. Feng, H. Kadara, H.-J. Kim, J. J. Lee, R. Mehran, W. K. Hong, R. Lotan, and I. I. Wistuba Expression of Interleukin-1 Receptor-Associated Kinase-1 in Non-Small Cell Lung Carcinoma and Preneoplastic Lesions Clin. Cancer Res., January 1, 2010; 16(1): 34 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. El Gammal, M. Bruchmann, J. Zustin, H. Isbarn, O. J.C. Hellwinkel, J. Kollermann, G. Sauter, R. Simon, W. Wilczak, J. Schwarz, et al. Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer Clin. Cancer Res., January 1, 2010; 16(1): 56 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Leav, J. Plescia, H. L. Goel, J. Li, Z. Jiang, R. J. Cohen, L. R. Languino, and D. C. Altieri Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer Am. J. Pathol., January 1, 2010; 176(1): 393 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mahalingam, E. C. Medina, J. A. Esquivel II, C. M. Espitia, S. Smith, K. Oberheu, R. Swords, K. R. Kelly, M. M. Mita, A. C. Mita, et al. Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels Clin. Cancer Res., January 1, 2010; 16(1): 141 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sato, J. Koinuma, M. Fujita, M. Hosokawa, T. Ito, E. Tsuchiya, S. Kondo, Y. Nakamura, and Y. Daigo Activation of WD Repeat and High-Mobility Group Box DNA Binding Protein 1 in Pulmonary and Esophageal Carcinogenesis Clin. Cancer Res., January 1, 2010; 16(1): 226 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Tsimberidou, F. Braiteh, D. J. Stewart, and R. Kurzrock Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial J. Clin. Oncol., December 20, 2009; 27(36): 6243 - 6250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Markowitz and M. M. Bertagnolli Molecular Basis of Colorectal Cancer N. Engl. J. Med., December 17, 2009; 361(25): 2449 - 2460. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Koroukian, F. Xu, P. M. Bakaki, M. Diaz -Insua, T. P. Towe, and C. Owusu Comorbidities, Functional Limitations, and Geriatric Syndromes in Relation to Treatment and Survival Patterns Among Elders With Colorectal Cancer J Gerontol A Biol Sci Med Sci, December 16, 2009; (2009) glp180v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Warin, W. H. Chambers, D. M. Potter, and S. V. Singh Prevention of Mammary Carcinogenesis in MMTV-neu Mice by Cruciferous Vegetable Constituent Benzyl Isothiocyanate Cancer Res., December 15, 2009; 69(24): 9473 - 9480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stevenson, W. Mostertz, C. Acharya, W. Kim, K. Walters, W. Barry, K. Higgins, S. A. Tuchman, J. Crawford, G. Vlahovic, et al. Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma Clin. Cancer Res., December 15, 2009; 15(24): 7553 - 7561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Meyerhardt, E. L. Giovannucci, S. Ogino, G. J. Kirkner, A. T. Chan, W. Willett, and C. S. Fuchs Physical Activity and Male Colorectal Cancer Survival Arch Intern Med, December 14, 2009; 169(22): 2102 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Chang, C.-Y. Hu, C. Eng, J. M. Skibber, and M. A. Rodriguez-Bigas Practical Application of a Calculator for Conditional Survival in Colon Cancer J. Clin. Oncol., December 10, 2009; 27(35): 5938 - 5943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Horn, S. E. Dahlberg, A. B. Sandler, A. Dowlati, D. F. Moore, J. R. Murren, and J. H. Schiller Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501 J. Clin. Oncol., December 10, 2009; 27(35): 6006 - 6011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. DeRycke, J. D. Andersen, K. M. Harrington, S. E. Pambuccian, S. E. Kalloger, K. L.M. Boylan, P. A. Argenta, and A. P.N. Skubitz S100A1 Expression in Ovarian and Endometrial Endometrioid Carcinomas Is a Prognostic Indicator of Relapse-Free Survival Am J Clin Pathol, December 1, 2009; 132(6): 846 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mizokami, E. Koh, K. Izumi, K. Narimoto, M. Takeda, S. Honma, J. Dai, E. T Keller, and M. Namiki Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone Endocr. Relat. Cancer, December 1, 2009; 16(4): 1139 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Darb-Esfahani, R. M Wirtz, B. V Sinn, J. Budczies, A. Noske, W. Weichert, A. Faggad, S. Scharff, J. Sehouli, G. Oskay-Ozcelik, et al. Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue Endocr. Relat. Cancer, December 1, 2009; 16(4): 1229 - 1239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Karacay, R. M. Sharkey, D. V. Gold, D. R. Ragland, W. J. McBride, E. A. Rossi, C.-H. Chang, and D. M. Goldenberg Pretargeted Radioimmunotherapy of Pancreatic Cancer Xenografts: TF10-90Y-IMP-288 Alone and Combined with Gemcitabine J. Nucl. Med., December 1, 2009; 50(12): 2008 - 2016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Richardson, E. Weller, S. Jagannath, D. E. Avigan, M. Alsina, R. L. Schlossman, A. Mazumder, N. C. Munshi, I. M. Ghobrial, D. Doss, et al. Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma J. Clin. Oncol., December 1, 2009; 27(34): 5713 - 5719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Makridakis, T. Phipps, S. Srivastav, and J. K. V. Reichardt PCR-free method detects high frequency of genomic instability in prostate cancer Nucleic Acids Res., December 1, 2009; 37(22): 7441 - 7446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y.C. Heng, W. Xie, M. M. Regan, M. A. Warren, A. R. Golshayan, C. Sahi, B. J. Eigl, J. D. Ruether, T. Cheng, S. North, et al. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study J. Clin. Oncol., December 1, 2009; 27(34): 5794 - 5799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hoenerhoff, H. H. Hong, T.-v. Ton, S. A. Lahousse, and R. C. Sills A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer Toxicol Pathol, December 1, 2009; 37(7): 835 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Gould Rothberg, A. J. Berger, A. M. Molinaro, A. Subtil, M. O. Krauthammer, R. L. Camp, W. R. Bradley, S. Ariyan, H. M. Kluger, and D. L. Rimm Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms J. Clin. Oncol., December 1, 2009; 27(34): 5772 - 5780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. B. Godoy and D. P. Naidich Subsolid Pulmonary Nodules and the Spectrum of Peripheral Adenocarcinomas of the Lung: Recommended Interim Guidelines for Assessment and Management Radiology, December 1, 2009; 253(3): 606 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Somwar, D. Shum, H. Djaballah, and H. Varmus Identification and Preliminary Characterization of Novel Small Molecules That Inhibit Growth of Human Lung Adenocarcinoma Cells J Biomol Screen, December 1, 2009; 14(10): 1176 - 1184. [Abstract] [PDF]
|
|
|
|
|
|
G. A. Zamboni, M. D'Onofrio, A. Idili, R. Malago, R. Iozzia, E. Manfrin, and R. P. Mucelli Ultrasound-Guided Percutaneous Fine-Needle Aspiration of 545 Focal Pancreatic Lesions Am. J. Roentgenol., December 1, 2009; 193(6): 1691 - 1695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hernandez and R. J. Mermelstein A Conceptual Framework for Advancing Melanoma Health Disparities Research Arch Dermatol, December 1, 2009; 145(12): 1442 - 1446. [Full Text] [PDF]
|
|
|
|
 |
|
 H Endo, K Hosono, T Fujisawa, H Takahashi, M Sugiyama, K Yoneda, Y Nozaki, K Fujita, M Yoneda, M Inamori, et al. Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions Gut, December 1, 2009; 58(12): 1637 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Davidson, N. Wang, M. S. Shah, J. R. Lupton, I. Ivanov, and R. S. Chapkin n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon Carcinogenesis, December 1, 2009; 30(12): 2077 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshida, K. Nakachi, K. Imai, J. B. Cologne, Y. Niwa, Y. Kusunoki, and T. Hayashi Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose Carcinogenesis, December 1, 2009; 30(12): 2037 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kamat, S. T. Tharakan, B. Sung, and B. B. Aggarwal Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF-{kappa}B and Upregulation of TRAIL Receptors Cancer Res., December 1, 2009; 69(23): 8958 - 8966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Weige, K. F. Allred, and C. D. Allred Estradiol Alters Cell Growth in Nonmalignant Colonocytes and Reduces the Formation of Preneoplastic Lesions in the Colon Cancer Res., December 1, 2009; 69(23): 9118 - 9124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Avissar, M. D. McClean, K. T. Kelsey, and C. J. Marsit MicroRNA expression in head and neck cancer associates with alcohol consumption and survival Carcinogenesis, December 1, 2009; 30(12): 2059 - 2063. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH |
